ACUTE MYELOID LEUKEMIA IN REMISSION
Clinical trials for ACUTE MYELOID LEUKEMIA IN REMISSION explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA IN REMISSION trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA IN REMISSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could less be more? new study tests lower drug dose to keep AML in check
Disease control Recruiting nowThis study looks at whether a lower dose of the drug venetoclax can be safely given to people whose acute myeloid leukemia (AML) is in remission. The goal is to reduce serious side effects like low white blood cell counts while still preventing the cancer from coming back. About …
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE2 • Sponsor: Northwell Health • Aim: Disease control
Last updated May 26, 2026 05:55 UTC
-
New chemo combo aims to cut relapse after stem cell transplant for AML patients
Disease control Recruiting nowThis study compares two chemotherapy regimens given before a stem cell transplant in 302 adults with AML in remission. The goal is to see if a stronger drug (clofarabine) can improve survival at 2 years compared to the standard drug (fludarabine). Participants must be at least 18…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE2 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated May 26, 2026 05:49 UTC
-
New stem cell filtering technique aims to improve blood cancer transplants
Disease control Recruiting nowThis study tests a stem cell transplant method for people under 25 with certain blood cancers. The approach filters out specific immune cells from donated stem cells to lower the risk of graft-versus-host disease (a serious complication) while helping the new cells grow. Up to 40…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New drug hopes to keep leukemia away after transplant
Disease control Recruiting nowThis early-phase study tests an experimental drug called ziftomenib in adults with acute myeloid leukemia (AML) who have had a stem cell transplant. The goal is to find a safe dose and see if the drug can help prevent the cancer from coming back. About 22 participants will take t…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Radioactive antibody blasts cancer before stem cell rescue in High-Risk leukemia trial
Disease control Recruiting nowThis study tests a radioactive antibody (211At-BC8-B10) followed by a donor stem cell transplant for people with high-risk leukemia or myelodysplastic syndrome (MDS) that has come back or not responded to treatment. The antibody targets cancer cells and delivers radiation, then c…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE1, PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC